BBTX Conversion Disclosure
Ra Capital Management, L.p. · SEC Form 4 · Filed Nov 3, 2026
Conversion
Calculated transaction value
$0
Ra Capital Management, L.p. Director / Ten Percent Owner
BBTX
Transaction date
Nov 2, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 1 day later
BBTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series A-2 Preferred Stock on Common Stock
- Quantity / price
- 52,932 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001231919-26-001533
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$46.64M
Buys / sales
4 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bambusa Therapeutics, Inc. BBTX | Buy | Nov 2, 2026 | $2.64M |
| Bambusa Therapeutics, Inc. BBTX Current | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | Not reported |
| Bambusa Therapeutics, Inc. BBTX | Buy | Nov 2, 2026 | $37.36M |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | $0 |
| Bambusa Therapeutics, Inc. BBTX | Conversion | Nov 2, 2026 | Not reported |
| Bambusa Therapeutics, Inc. BBTX | Buy | Oct 30, 2026 | $2.7M |
| Bambusa Therapeutics, Inc. BBTX | Buy | Oct 30, 2026 | $3.94M |